LabCorp
LH
#1053
Rank
NZ$37.46 B
Marketcap
NZ$450.83
Share price
0.63%
Change (1 day)
1.36%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

EPS for LabCorp (LH)

EPS in 2025 (TTM): NZ$17.62

According to LabCorp's latest financial reports the company's current EPS (TTM) is NZ$17.02. In 2024 the company made an earnings per share (EPS) of NZ$14.76 an increase over its 2023 EPS that were of NZ$7.80.

EPS history for LabCorp from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.6219.4%
2024NZ$14.7689.15%
2023NZ$7.80-66.26%
2022NZ$23.13-43.33%
2021NZ$40.8154.11%
2020NZ$26.4889.43%
2019NZ$13.98-3.33%
2018NZ$14.46-29.7%
2017NZ$20.5775.74%
2016NZ$11.7163.19%
2015NZ$7.17-28.4%
2014NZ$10.02-6.13%
2013NZ$10.675.2%
2012NZ$10.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IDEXX Laboratories
IDXX
NZ$21.10 24.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$14.35-15.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.46-108.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.10-81.77%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.35-102.05%๐Ÿ‡บ๐Ÿ‡ธ USA